Eastman Chemical Co. 10-Q Summary: Quarter Ended September 30, 1998
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Eastman Chemical Company for the period ended September 30, 1998. The company operates in three primary segments: Specialty and Performance, Core Plastics, and Chemical Intermediates. The reporting period covers the third quarter and the first nine months of 1998.
Key Financial Metrics
| Metric | Q3 1998 | Q3 1997 | 9 Months 1998 | 9 Months 1997 |
|---|---|---|---|---|
| Sales | $1,131 million | $1,145 million | $3,444 million | $3,524 million |
| Net Earnings | $80 million | $96 million | $251 million | $258 million |
| Diluted EPS | $1.00 | $1.22 | $3.15 | $3.28 |
| Gross Margin | 23.1% | 25.2% | 23.6% | 23.6% |
| Operating Earnings | $141 million | $148 million | $438 million | $439 million |
| Cash from Operations (9mo) | $459 million (vs. $509 million prior year) | |||
| Long-Term Borrowings | $1,821 million (as of Sept 30, 1998) | |||
| Cash and Equivalents | $86 million (as of Sept 30, 1998) |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 1% in Q3 and 2% for the nine-month period. While sales volumes increased across most segments (notably Core Plastics), selling prices declined due to global economic conditions and industry overcapacity.
- Earnings Impact: Net earnings fell 17% in Q3 and 3% for the nine months. A significant factor was an $11 million non-deductible fine for a Sherman Act antitrust violation recorded in Q3 1998. Conversely, 1997 results included a gain from a patent infringement award.
- Cost Structure: Raw material costs (propane, paraxylene, natural gas) were lower than 1997 levels. Selling, general, and administrative expenses decreased 12% in Q3 due to timing and labor reductions.
- Segment Performance:
- Specialty and Performance: Sales down 2% (Q3); earnings impacted by the antitrust fine.
- Core Plastics: Sales up 3% (Q3) driven by volume growth in EASTAPAK polymers; operating earnings improved from a loss of $10 million in 1997 to $3 million in 1998.
- Chemical Intermediates: Sales down 8% (Q3) due to lower prices; operating earnings down 36%.
Outlook, Risks, and Contingencies
- Guidance: Management anticipates challenges in improving earnings in Q4 1998 due to continued global economic weakness and price pressure. Capital expenditures for 1998 are estimated at $500-$550 million.
- Holston Defense Termination: The company will cease managing the Holston Army Ammunition Plant on December 31, 1998. While $35 million in termination and pension curtailment liabilities were recognized, the company expects full reimbursement from the Department of the Army, resulting in no net earnings impact.
- Year 2000 Issue: The company is on track to remediate business systems by year-end 1998 and manufacturing systems by early 1999. Total costs are expected to be under $20 million with no material financial impact anticipated.
- Liquidity: The company maintains an $800 million revolving credit facility with no outstanding balance. Commercial paper outstanding was $296 million at 5.72% interest.
Investor Verification Checklist
- Verify the timing and certainty of the Department of the Army reimbursement regarding the Holston Defense Corporation termination costs.
- Monitor the impact of the $11 million antitrust fine on future cash flows (payable over five years) and potential follow-on litigation.
- Assess the sustainability of volume growth in the Core Plastics segment against the backdrop of industry overcapacity and price erosion.
- Review the progress of the "Advantaged Cost 2000" initiative to ensure the targeted $500 million in cost reductions are achievable.
- Confirm the status of Year 2000 remediation for critical third-party suppliers and customers.